The Great Debate! Should you treat pre-clinical RA? "The more good factors you have, the less likely you will develop RA" - Janet Pope Never smoker, normal BMI, low EtOH, exercise, healthy diet @RheumNow #ACR22 https://t.co/jIMOn8ht6u

70% of #AOSD pts were females! Large HCA database study - incidence rate - 0.16 - 0.21 per 100,000 (similar to French studies). 24% required ICU level of care, 12% had PNA (fig) Mortality is higher than other cohorts - 3.2% #ACR22 @RheumNow abst#0829 https://t.co/fcFUnExYOE

🤓Active learning creates a greater + impact in patient care using cognitive errors metacognition - study by Dr Milne et al. ☑️Reflection, #metacognition enhances clinical competence, incorporate in curriculum #ACR22 @RheumNow #meded @rheumarhyme @PhRheumaJr @GerRheumDoc https://t.co/veefYToXBV

#ACR22 The Great Debate: to treat subclinical #Rheumatoidarthritis or not. @Janetbirdope counted hands manually in person. Let's check out the #socialmedia community. What is your definition of sub-clinical RA? @RheumNow

Romo works even better in higher risk patients. More ammunition to use up-front. Availability is a limiting factor though. @RheumNow #ACR22 #osteoporosis https://t.co/90X97jVJcP

Dr. Jack Cush discusses uptake of #telemedicine in 2020 and the relative decline of uptake since then: @RheumNow -- What's your take on continuing to use #telehealth for rheum visits? #ACR22 https://t.co/OB5Wnnq6Fh

“Go digital or go home” -- Dr Jack Cush says on #telemedicine in a session at #ACR22 @RheumNow https://t.co/4PzGgS900t

Dr. Megan Clowse gives 2 major tips on how rheumatologists can help avoid catastrophic pregnancies: ✳️Routinely ask open-ended Qs to promote HONEST dialogue about repro health ✳️Provide ACCURATE info & guidance using discussion guides and handouts #ACR22 @RheumNow @rheumarhyme https://t.co/qXwKMdJmR8

Infections in pre-RA: a cause or a consequence? Rheumatoid arthritis is known to be associated with a higher risk of infections, and this occurs for multiple reasons: immune dysfunction, systemic inflammation, comorbidities, and treatments. https://t.co/N91Goop92l https://t.co/yvnRrsHSCB

• https://bit.ly/3AaHTiP

Dr. Michael Holers on preclinical RA "Individuals who are anti-CCP positive are not clinically well. We just can't see what is going on" @RheumNow #ACR22

Emphasis that drug holiday is NOT drug retirement in osteoporosis. Ideal time to re-initiate is quite uncertain however. Continue to monitor DEXA and fracture risk factors. @RheumNow #ACR22 #osteoporosis https://t.co/iLKrxdzpAR

Valero et al. Combined biologics in PsA. @RheumNow #ACR22 Abstr1044 https://t.co/7nNf0Ktf0M https://t.co/CIE9BnBFvx

• Combined Biological or Targeted Therapy in Spondyloarthritis: Experience from a…

The Great Debate! Should you treat pre-clinical RA? First - likelihood of RA? If you have +ACPA or RF in sputum, there is 67% chance of developing clinical RA! @RheumNow #ACR22 https://t.co/K7pUhvbEDR

💠CYC confers a 27% risk of congenital malformations and ⬆️miscarriage rate 💠Contraception is recommended during use and 3 mos after tx #ACR22 @Rheumnow https://t.co/A73vCMZdxd

Can we predict PsA incidence and prevalence trends? Germany long-term projection 2040 3 scenarios: 1. increase 5%/yr 2. stable 3. decrease 5%/yr. Best scenario (3) = peak diagnoses in 2028. Are medical resources ready for it? https://t.co/ws87zDukuM Abs#1019 #ACR22 @Rheumnow https://t.co/dqkfrag0w2

• Number of Patients with Psoriatric Arthritis (PsA) in Germany Until 2040: Proje…